Virological outcome and frequency of low-level viremia in patients receiving generic dolutegravir-containing regimen at a large tertiary care clinic in Western India
Conclusion: DTG is well tolerated and effective in suppressing HIV across all antiretroviral treatment categories. The rate of persistent LLV is low in DTG-containing therapy.
Source: Indian Journal of Sexually Transmitted Diseases - Category: Infectious Diseases Authors: Atul K Patel Ketan K Patel Sanjay Pujari Jagdish K Patel Ambuj Kumar Source Type: research
More News: Brain | HIV AIDS | India Health | Infectious Diseases | Neurology | STDs | Study | Virology